Back to Archived News
Techalt, Inc. Announces U.S. Patent Office Grants Petition to Revive Review of the Patent Application for Stanís Rodeo Ointment
Wednesday, August 13, 2008
Seattle, WA -- Techalt, Inc. (Pink Sheets: TCLT) ("Techalt" or "Company") announced that the petition for revival of the patent application filed with the United States Patent and Trademark Office ("USPTO"), covering the formulations and processing of Stan's Rodeo Ointment ("SRO"), has been granted by the USPTO following the unintentional abandonment of the patent under 37 CFR 1.137(b). The petition decision has been routed from the office of petition review to the Technology Center Legal Instrument Examiners for final review and comment on the merits of the patent application.
Stanley Johnson, creator of SRO, remarked, "We are pleased to restart the patent process in advance of our anticipated increase in marketing activities over the next 12 months."
Techalt is in process of securing financing for (i) expanding SRO's distribution and marketing (ii) obtaining an over the counter designation from the United States Food and Drug Administration.
About Stan's Rodeo Ointment ("SRO")
SRO is a sports cream product designed to accelerate the healing for abrasions, lacerations, blisters and other open wounds to the skin, while diminishing the pain from such injuries. Developed by Stanley Johnston, former head athletic trainer for the Los Angeles Dodgers, SRO is available by prescription and used by Olympic and professional athletes. Techalt acquired the rights to develop Stan's Blister Rub ("SBR"), which strengthens the healed skin to reduce the reoccurrence of blisters. The Company anticipates that a patent will be issued sometime in 2008.
Techalt is a public holding company dedicated to pursuing acquisition, licensing and financing opportunities with start-up and mid-stage companies. Techalt focuses on companies with innovative or alternative technologies, particularly in the software, communications, environmental and health and wellness sectors.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("the Exchange Act"), as such, may involve risks and uncertainties. Forward-looking statements are based upon certain assumptions and describe future plans, strategies and expectations, are generally identifiable by the use of words as "believe," "expect," "intend," "anticipate," "project," or other similar expressions. Forward-looking statements relate to, among other things, future performance, and perceived opportunities in the market and statements regarding the Company's mission and vision. The Company's actual results, performance and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements. Additional factors could materially affect these forward-looking statements and/or predictions include, among other things: (1) managing acquisitions and expansion of operations; (2) obtaining necessary financing and managing existing debt; (3) completing the investigation, acquisition and integration of new business opportunities; (4) complying with federal, state and local government and international regulations; and (5) other factors over which we have little or no control.
Back to Archived News